Impact of quality of response on survival outcomes among multiple myeloma patients treated with novel agents - a retrospective analysis.

Irena Ćojbašić Miodrag Vučić Ivan Tijanić Žarko Ćojbašić

Published in: Sao Paulo medical journal = Revista paulista de medicina (2022)

This analysis demonstrated that the quality of response after application of first-line treatment using novel agent-based regimens among multiple myeloma patients was a prognostic factor for PFS and OS, which are the most clinically relevant outcomes.

Keyphrases

prognostic factors
multiple myeloma
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
quality improvement
type diabetes
metabolic syndrome
patient reported outcomes
insulin resistance
glycemic control